In this webinar, Oat Khodthong, PhD from Aldevron and Garrett Rettig, PhD from Integrated DNA Technologies (IDT) will highlight how our partnership and services will accelerate new CRISPR-based therapies to support genomic medicine. IDT will spotlight their capabilities in chemistry and oligo production for high-quality CRISPR gRNAs, while Aldevron will detail an expertise in cGMP CRISPR nuclease and RNP manufacturing and characterization*. We have brought our synergistic services together to provide drug development partners with complete CRISPR genome editing solutions.
LEARNING OBJECTIVES FROM THIS WEBINAR:
- IDT’s capability of manufacturing chemically-modified, high-quality guide RNAs
- Overview of the analytical testing to fully characterize the RNP complex
- Benefits of working with Aldevron and IDT for your CRISPR-RNP project
*Aldevron provides RNPs only to customers who are duly licensed, including to make and have made RNPs, for their intended use.